Group 1 - Blackstone Inc. is recognized as one of the best cheap blue chip stocks to buy, with analysts highlighting its potential [1] - Blackstone Life Sciences announced a funding agreement to advance the clinical development of bleximenib, an investigational oral menin inhibitor for acute myeloid leukemia (AML), which is noted for its challenging treatment and low survival rates [1] - Johnson & Johnson and funds managed by Blackstone Life Sciences will co-finance ongoing and future clinical trials of bleximenib, marking their first co-funding agreement [3] Group 2 - RBC Capital initiated coverage of Blackstone Inc. with an Outperform rating and a price target of $179, citing the company's first-mover advantage in launching a private wealth team and its potential to benefit from retail growth and an improving real estate cycle [4] - Blackstone Inc. provides investment and fund management services across several segments, including Real Estate, Private Equity, Credit and Insurance, and Hedge Fund Solutions [5]
Is Blackstone Inc. (BX) One of the Best Cheap Blue Chip Stocks to Buy According to Analysts?